Veradigm (NASDAQ:MDRX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRXFree Report) in a research report released on Monday morning. The brokerage issued a hold rating on the software maker’s stock.

A number of other brokerages have also weighed in on MDRX. TD Cowen cut their price objective on Veradigm from $26.00 to $15.00 and set a buy rating on the stock in a report on Tuesday, May 28th. Deutsche Bank Aktiengesellschaft reissued a hold rating and issued a $10.00 price objective (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Five research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Veradigm has a consensus rating of Hold and an average target price of $12.00.

Read Our Latest Research Report on Veradigm

Veradigm Price Performance

Shares of MDRX stock opened at $9.50 on Monday. The stock’s 50-day simple moving average is $8.17 and its 200-day simple moving average is $8.82. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $14.09.

Institutional Trading of Veradigm

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Tyro Capital Management LLC acquired a new stake in Veradigm during the first quarter worth about $9,055,000. Horrell Capital Management Inc. acquired a new stake in Veradigm during the first quarter worth about $385,000. Meadow Creek Wealth Advisors LLC acquired a new stake in Veradigm during the first quarter worth about $83,000. Vanguard Group Inc. boosted its position in Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after purchasing an additional 95,291 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in Veradigm by 117.8% during the fourth quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after purchasing an additional 3,140,483 shares in the last quarter.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.